Dr. Russell Ware, MD

NPI: 1174526735
Total Payments
$72,502
2024 Payments
$33,595
Companies
7
Transactions
45

Payment Breakdown by Category

Consulting$40,646 (56.1%)
Travel$17,222 (23.8%)
Other$13,735 (18.9%)
Food & Beverage$898.64 (1.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $40,646 7 56.1%
Travel and Lodging $17,222 15 23.8%
Honoraria $13,735 3 18.9%
Food and Beverage $898.64 20 1.2%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $23,675 4 $0 (2024)
Novo Nordisk Health Care AG $21,319 4 $0 (2024)
Agios Pharmaceuticals, Inc. $11,221 17 $0 (2020)
CSL Behring $8,720 9 $0 (2020)
Merck Sharp & Dohme LLC $7,351 9 $0 (2024)
GENZYME CORPORATION $113.33 1 $0 (2022)
Apellis Pharmaceuticals, Inc. $103.36 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $33,595 14 Novo Nordisk Health Care AG ($21,319)
2023 $103.36 1 Apellis Pharmaceuticals, Inc. ($103.36)
2022 $12,613 3 Novartis Pharmaceuticals Corporation ($12,500)
2021 $6,250 1 Novartis Pharmaceuticals Corporation ($6,250)
2020 $4,860 2 Agios Pharmaceuticals, Inc. ($3,300)
2019 $15,081 24 Agios Pharmaceuticals, Inc. ($7,921)

All Payment Transactions

45 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
06/19/2024 Novartis Pharmaceuticals Corporation Consulting Fee Cash or cash equivalent $4,925.00 General
05/27/2024 Novo Nordisk Health Care AG Travel and Lodging In-kind items and services $12,298.00 General
05/27/2024 Novo Nordisk Health Care AG Consulting Fee Cash or cash equivalent $8,181.25 General
05/27/2024 Novo Nordisk Health Care AG Travel and Lodging In-kind items and services $764.00 General
05/27/2024 Novo Nordisk Health Care AG Food and Beverage In-kind items and services $76.00 General
04/29/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $5,490.00 General
04/29/2024 Merck Sharp & Dohme LLC Travel and Lodging Cash or cash equivalent $150.00 General
04/19/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Travel and Lodging In-kind items and services $291.00 General
Category: ONCOLOGY
04/19/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Travel and Lodging In-kind items and services $196.50 General
Category: ONCOLOGY
04/19/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $58.81 General
Category: ONCOLOGY
04/19/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $51.43 General
Category: ONCOLOGY
04/19/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $49.76 General
Category: ONCOLOGY
04/18/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Travel and Lodging In-kind items and services $734.19 General
Category: ONCOLOGY
04/18/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Travel and Lodging In-kind items and services $329.00 General
Category: ONCOLOGY
03/28/2023 Apellis Pharmaceuticals, Inc. Empaveli (Drug) Food and Beverage Cash or cash equivalent $103.36 General
Category: Hematology
12/11/2022 GENZYME CORPORATION Food and Beverage In-kind items and services $113.33 General
04/19/2022 Novartis Pharmaceuticals Corporation PROMACTA (Drug) Consulting Fee Cash or cash equivalent $6,250.00 General
Category: ONCOLOGY
01/18/2022 Novartis Pharmaceuticals Corporation PROMACTA (Drug) Consulting Fee Cash or cash equivalent $6,250.00 General
Category: ONCOLOGY
07/06/2021 Novartis Pharmaceuticals Corporation PROMACTA (Drug) Consulting Fee Cash or cash equivalent $6,250.00 General
Category: ONCOLOGY
09/09/2020 CSL Behring Honoraria Cash or cash equivalent $1,560.00 General
08/25/2020 Agios Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $3,300.00 General
08/05/2019 CSL Behring Honoraria Cash or cash equivalent $6,070.00 General
08/05/2019 CSL Behring Travel and Lodging Cash or cash equivalent $81.60 General
08/05/2019 CSL Behring Food and Beverage In-kind items and services $45.00 General
08/05/2019 CSL Behring Food and Beverage In-kind items and services $30.00 General

About Dr. Russell Ware, MD

Dr. Russell Ware, MD is a Pediatric Hematology-Oncology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174526735.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Russell Ware, MD has received a total of $72,502 in payments from pharmaceutical and medical device companies, with $33,595 received in 2024. These payments were reported across 45 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($40,646).

Practice Information

  • Specialty Pediatric Hematology-Oncology
  • Other Specialties Pediatrics
  • Location Cincinnati, OH
  • Active Since 05/27/2005
  • Last Updated 02/02/2015
  • Taxonomy Code 2080P0207X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1174526735

Products in Payments

  • PROMACTA (Drug) $18,750
  • TIBSOVO (Drug) $7,921
  • KEYTRUDA (Biological) $1,711
  • Empaveli (Drug) $103.36

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Hematology-Oncology Doctors in Cincinnati